A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7289-7294

  Vacheron, Sonia ^a   Renno, Toufic ^a   Acha Orbea, Hans ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION;

EID: 0030880884     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7289-7294.1997     Document Type: Article

References (43)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Müller, A. Vessaz-Shaw, R. Fuchs, K. Blöchlinger, P. Rollini, J. Billote, M. Sarafidou, H. R. MacDonald, and H. Diggelmann, 1991. Clonal deletion of Vβ14 positive T cells in mammary tumor virus transgenic mice. Nature 350:207-211.
3. Acha-Orbea, H., R. M. Zinkernagel, and H. Hengartner. 1985. Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur. J. Immunol. 15:31-36.
4. Ardavin, C., G. Waanders, I. Ferrero, F. Anjuere, H. Acha-Orbea, and H. R. MacDonald. 1996. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells. J. Immunol. 157:2789-2794.
5. Chervonsky, A. V., J. Xu, A. K. Barlow, M. Khery, R. A. Flavell, and C. A. J. Janeway. 1995. Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to Pr°Pagate MMTV. Immunity 3:139-146.
6. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumor virus. Nature 350:203-207.
7. Crowley, M. T., K. Inaba, M. D. Witmer Pack, S. Gezelter, and R. M. Steinman. 1990. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J. Immunol. Methods 133:55-66.
8. DeKruyff, R. H., S. T. Ju, J. Laning, H. Cantor, and M. E. Dorf. 1986. Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants. J. Immunol. 137:1109-1114.
9. a - a new congenic mouse strain. Transplantation 37:322-324.
10. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
11. Golovkina, T. V., A. Chervonsky, J. A. Prescott, C. A. J. Janeway, and S. R. Ross. 1994. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:439-446.
12. Held, W., H. Acha-Orbea, H. R. MacDonald, and G. A. Waanders. 1994. Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol. Today 15:184-190,
13. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
14. a (Mtv-7). J. Exp. Med. 175:1623-1633.
15. Held, W., G. A. Waanders, H. Acha-Orbea, and H. R. MacDonald. 1994. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J. Exp. Med. 180:2347-2351.
16. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
17. Howard, D. K., and J. Schlom. 1978. Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro. Proc. Natl. Acad. Sci. USA 75:5718-5722.
18. Inaba, M., K. Inaba, M. Hosono, T. Kumamoto, T. Ishidia, S. Muramatsu, T. Masuda, and S. Ikehara. 1991. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. J. Exp. Med. 173:549-559.
19. Jarvis, C. D., R. N. Germain, G. L. Hager, M. Damschroder, and L. A. Matis. 1994. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J. Immunol. 152:1032-1038.
20. β-specific stimulation of human T cells by staphylococcal toxins. Science 244:811-813.
21. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198-1214.
22. Kappler, J. W., U. D. Staerz, J. White, and P. C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 332:35-40.
23. Lasfargues, E. Y., B. Kramarsky, J. C. Lasfargues, and D. H. Moore. 1974. Detection of mouse mammary tumor virus in cat kidney cells infected with purified B particles from RIII milk. J. Natl. Cancer Inst. 53:1831-1833.
24. Lasfargues, E. Y., A. B. Vaidya, J. C. Lasfargues, and D. H. Moore. 1976. In vitro susceptibility of mink lung cells to the mouse mammary tumor virus. J. Natl. Cancer Inst. 57:447-449.
25. Le Bon, A., B. Lucas, F. Vasseur, C. Penit, and M. Papiernik. 1996. In vivo T cell response to viral superantigen. Selective migration rather than proliferation. J. Immunol. 156:4602-4608.
26. + T cells. J. Exp. Med. 170:135-143.
27. Luther, S., A. Gulbranson-Judge, H. Acha-Orbea, and I. C. M. MacLennan. 1997. Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J. Exp. Med. 158:551-562.
28. 27a.Luther, S. A., S. Vacheron, I. Xenarios, L. Scarpellino, an H. Acha-Orbea. Unpublished data. 27b.Luthi, F., H. Acha-Orbea, and H. Diggelmann. Unpublished data.
29. 27a.Luther, S. A., S. Vacheron, I. Xenarios, L. Scarpellino, an H. Acha-Orbea. Unpublished data. 27b.Luthi, F., H. Acha-Orbea, and H. Diggelmann. Unpublished data.
30. Mazda, O., Y. Watanabe, J.-I. Gyotoku, and Y. Katsura. 1991. Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus. J. Exp. Med. 173:539-547.
31. Metlay, J. P., M. D. Witmer Pack, R. Agger, M. T. Crowley, D. Lawless, and R. M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-1771.
32. a determinants. J. Immunol. 143:39-44.
33. Mollick, J. A., R. G. Cook, and R. R. Rich. 1989. Class II MHC molecules are specific receptors for staphylococcal enterotoxins. Science 244:817-820.
34. Ozato, K., N. Mayer, and D. H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and la antigens. J. Immunol. 124:533-540.
35. Pierres, A., P. Naquet, A. Van Agthoven, F. Bekkhoucha, F. Denizot, Z. Mishal, A. M. Schmilt-Verhulst, and M. Pierres. 1984. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of la-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3 +) subsets among anti-Ia cytolytic T cell clones. J. Immunol. 132:2775-2782.
36. Sarmiento, M., D. P. Dialynas, D. W. Lancki, K. A. Wall, M. I. Lorber, M. R. Loken, and F. W. Fitch. 1982. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:135-169.
37. Staerz, U. D., H. Rammensee, J. Bendetto, and M. Bevan. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:3994-4000.
38. Steinman, R., L. Hoffman, and M. Pope. 1995. Maturation and migration of cutaneous dendritic cells. J. Investig. Dermatol. 105:2S-7S.
39. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580-596.
40. Vaidya, A. B., E. Y. Lasfargues, G. Heubel, J. C. Lasfargues, and D. H. Moore. 1976. Murine mammary tumor virus: characterization of infection of nonmurine cells. J. Virol. 18:911-917.
41. Vaidya, A. B., E. Y. Lasfargues, J. B. Sheffield, and W. G. Coutinho. 1978. Murine mammary tumor virus (MuMTV) infection of an epithelial cell line established from C57BL/6 mouse mammary glands. Virology 90:12-22.
42. Wall, K. A., M. I. Lorber, M. R. Loken, S. McClatchey, and F. W. Fitch. 1983. Inhibition of proliferation of Mls- and la-reactive cloned T cells by a monoclonal antibody against a determinant shared between I-A and I-E. J. Immunol. 131:1056-1064.
43. a determinants. J. Exp. Med. 169:1-12.